Pathogenesis, clinical signs, and therapy for eye involvement in atopy;Pathogenese, klinik und therapie der augenbeteiligung bei atopie

Ophthalmologe

Volumn 96, Issue 7, 1999, Pages 473-488

  Reinhard, Thomas ^a   Ruzicka, T ^b   Sundmacher, R ^b  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ANTIHISTAMINIC AGENT; CORTICOSTEROID; CYCLOSPORIN A; PROSTAGLANDIN SYNTHASE INHIBITOR;

ATOPY; CRYOTHERAPY; HUMAN; HYPERSENSITIVITY; KERATOCONJUNCTIVITIS; KERATOPLASTY; NEURODERMATITIS; REVIEW; T LYMPHOCYTE;

ADULT; CHILD; CONJUNCTIVITIS, ALLERGIC; DERMATITIS, ATOPIC; DIAGNOSIS, DIFFERENTIAL; HUMANS; PROGNOSIS;

EID: 0032795175     PISSN: 0941293X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003470050441     Document Type: Review

References (93)

1. Abelson MB, Paradis A, George MA (1990) Effects of Vasocon A in the allergen challenge model of acute allergie conjunctivitis. Arch Ophthalmol 108:520-524
2. Allen BR, Sowden JM, Berth-Jones et al (1991) Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis. Lancet 338:137-140
3. Amemiya T, Matsuda H, Uehara M (1980) Ocular findings in atopic dermatitis with special reference to the clinical features of atopic cataract. Ophthalmologica 180:129-132
4. Arriaga F, Rombaut N (1990) Absence of central effects of levocabastine eye drops. Allergy 45:552-554
5. Aswad MI, Tauber J, Baum J (1988) Plasmapheresis treatment in patients with severe atopic keratoconjunctivitis. Ophthalmology 95:444-447
6. Beetham WP (1940) Atopic cataracts. Arch Ophthalmol 24:21-37
7. BenEzra S, Brodsky M,Cohen E (1986) Cyclosporine eyedrops for the treatment of severe vernal keratoconjunctivitis. Am J Ophthalmol 101:278-282
8. Besnier E (1892) Première note et observations preliminaires pour servir d'introduction à l'étude diathésique. Ann Dermatol Syphiligr 4:634
9. Bhan AK, Fujikawa LS, Foster CS (1982) T-Cell subsets and Langerhans cells in normal and diseased conjunctiva. Am J Ophthalmol 94:205-212
10. Björkstén B, Kjellmann NIM (1989) Double blind studies with levocabastine, sodium cromolycate, and placebo in the topical treatment of children with allergic conjunctivitis. In: Mygind N, Naclerio RM (eds) Rhinoconjunctivitis. Hogrefe and Huber, Göttingen, pp 49-50
11. Björkstén B (1991) Atopic prophylaxis. In: Ruzicka T, Ring J, Przybilla B (eds) Handbook of atopic eczema. Springer, Berlin Heidelberg New York, pp 339-344
12. Bleik JH, Tabbara KF (1991) Topical cyclosporine in vernal keratoconjunctivitis. Ophthalmology 98:1679-1684
13. Böhm I, Baur R (1997) Th1-Zellen, Th2-Zellen und atopische Dermatitis. Hautarzt 48:223-227
14. Bosse K (1991) Atopic eczema as a psychosomatic disease. In: Ruzicka T, Ring J, Przybilla B (eds). Handbook of atopic eczema. Springer, Berlin Heidelberg New York, pp 117-126
15. Brocq L (1891) Notes pour servir à l'histoire des neurodermites:du lichen circumscriptus des anciens auteurs, ou lichen simplex chronique de M. le Dr. E. Vidal. Ann Dermatol Syphiligr 2:97, 193
16. Brown WR, Hansen AE (1937) Arachidonic and linolic acid of the serum in normal and eczematous human subjects. Proc Soc Exp Biol Med 36:113-117
17. Bruynzeel-Koomen C, Wichen DF, Toonstra J, Berres L, Bruynzeel PLB (1986) The presence of IgE molecules on epidermal Langerhans cells in patients with atopic dermatitis. Arch Dermatol Res 278:199-205
18. Butrus SI, Leung DYM, Gellis S et al (1984) Vernal conjunctivitis in the hyperimmunoglobulinemia E syndrome. Ophthalmology 91:1213-1216
19. Coca AF, Cooke RA (1923) On classification of the phenomena of hypersensitiveness. J lmmunol 6:63
20. Coles RS, Laval J (1957) Retinal detachment occurring in cataract associated with neurodermatitis. Arch Ophthalmol 48:30-39
21. Cordes FC, Cordero-Moreno R (1946) Atopic cataracts. Am J Ophthalmol 29:402-407
22. Coster DJ (1997) Superficial keratopathy. ln:Tasman W, Jaeger EA (eds) Duane's clinical opthalmology, vol 4. Lippincott-Raven, Philadelphia New York, chapter 17, pp 1-13
23. Dogru M, Katakami C, Nakagawa N et al (1998) Impression cytology in atopic dermatitis. Ophthalmology 105:1478-1484
24. Duke-Elder S (1965) Diseases of the outer eye. Conjunctival diseases. In: Duke-Elder S (ed) System of ophthalmology, vol VIII. Kimpton, London, pp 446-448
25. Easty D, Entwistle C, Funk A et al (1975) Herpes simplex keratitis and keratoconus in the atopic patient. A clinical and immunological study. Trans Ophthalmol Soc UK 95:267-276
26. Foster CS, Calonge M (1990) Atopic keratoconjunctivitis. Ophthalmology 97:992-1000
27. Foster CS, Rice A, Dutt J (1991) lmmunopathology of atopic keratoconjunctivitis. Ophthalmology 98:1190-1196
28. Foster CS (1997) The eye in skin and mucous membrane disorders. ln: Tasman W, Jaeger EA (eds) Duane's clinical opthalmology, vol 5. Lippincott-Raven, Philadelphia New York, chapter 27, pp 1-41
29. Friedlaender MH (1993) Allergy and Immunology of the eye, 2nd edn. Raven Press, New York, pp 75-85
30. Frohn A, Weidle EG, Seelhorst A et al (1990) Augenbeteiligung bei Hyperimmunglobulinämie-E-Syndrom. Klin Mbl Augenheilkd 197:432-435
31. Garrity JA, Liegang TJ (1984) Ocular complications of atopic dermatitis. Can J Ophthalmol 19:21-24
32. Geggel HS (1994) Successful penetrating keratoplasty in a patient with severe atopic keratoconjunctivitis and elevated serum IgE level treated with long-term topical cyclosporin A. Cornea 13:543-545
33. Geha RS, Reinherz E, Leung D et al (1981) Deficiency of suppressor T cells in the hyperimmunoglobulin E syndrome. J Clin Invest 68:781-791
34. Gigli J, Baer RL (1979) Atopic dermatitis. In: Fitzpatrick T (ed). Dermatology in general medicine.Textbook and atlas, 2nd edn. McGraw-Hill, New York, pp 520-528
35. Gold MH, Picascia DD, Roenigk HH (1989) Treatment-resistant atopic dermatitis controlled with Cyclosporin A. lnt J Dermatol 28:481
36. Gorashi M, Akova YA, Tugal TI et al (1995) Penetrating keratoplasty in atopic keratoconjunctivitis. Cornea 14:610-613
37. Guzman A, Hernandez A, Climent A et al (1996) Non-steroid antiinflammatory solutions as alternative on allergic conjunctivitis treatment. Invest Ophthalmol Vis Sci 37 [Suppl]:311
38. Hemady Z, Bloberg F, Gellis S et al (1983) IgE production in vitro by human mononuclear blood cells: a comparison between atopic and nonatopic subjects. J Allergy Clin Immunol 71:324-330
39. Hoang-Xuan T, Prisant O, Hannouche D, Robin H (1997) Systemic Cyclosporine A in severe atopic keratoconjunctivitis. Ophthalmology 104:1300-1305
40. Hogan MJ (1952) Atopic keratoconjunctivitis. Trans Am Opthalmol Soc 50:265-281
41. Holland EJ, Olsen TW, Ketcham JM et al (1993) Topical Cyclosporin A in the treatment of anterior segment inflammatory disease. Cornea 12:413-419
42. Hornstein OP (1954) Guidelines for topical treatment in atopic eczema. In: Ruzicka T, Ring J, Przybilla B (eds) Handbook of atopic eczema. Springer, Berlin Heidelberg New York, pp 345-355
43. Hurlbut WB, Domonkos AN (1954) Cataract and retinal detachment associated with atopic dermatitis. Arch Ophthal 52:852-857
44. Insler MS, Lim JM, Queng JT et al (1987) Tear and serum IgE concentrations by tandem-R IgE immunoradiometric assay in allergic patients. Ophthalmology 94:945-948
45. Jacq PL, Sale Y, Cochener B et al. (1997) Kératocone, modification de la topography cornéene et allergie. J Fr Ophtalmol 20:97-102
46. Jay TL (1981) Clinical features and diagnosis in adult atopic keratoconjunctivitis and the effect of treatment with sodium cromoglycate. Br J Ophthalmol 65:335-340
47. Janssens M, Busche G (1991) Levocabastine: an effective topical treatment of allergic rhinoconjunctivitis.Clin Exp Allergy 21 [Suppl 2]:29-36
48. Johnson ML (1977) Prevalence of dermatologic disease among persons 1-74 years of age: United States. Advance data from vital and health statistics of the National Center for Health Statistics, No 4
49. Karel I, Myska V, Kvicalova E (1965) Ophthalmological changes in atopic dermatitis. Acta Dermatol Venerol 45:381-386
50. Kerr N, Stern GA (1992) Bacterial keratitis associated with vernal keratoconjunctivitis. Cornea 11:355-359
51. Kirkness CM, Ficker LA, Steele AD et al (1990) The success of penetrating keratoplasty for keratoconus. Eye 4:673-678
52. Kjellman NIM (1977) Atopic disease in seven-year-old children. Acta Paediatr Scand 66:465-471
53. Klemens F (1962) Dermatose, Katarakt und Ablatio retinae. Klin Monatsbl Augenheilkd 140:657-663
54. Lehmann P, Zheng P, Lavker RM et al (1983) Corticosteroid atrophy in human skin. A study by light, scanning and transmission electron microscopy. J Invest Dermatol 81:169-176
55. Liesegang T (1995) Atopic keratoconjunctivitis. In: Pepose J, Holland G, Wilhelmus K (eds) Ocular infection and immunity. Mosby, St. Louis, pp 376-390
56. Lyons CJ, Dart JKG, Aclimandos WA et al (1990) Sclerokeratitis after keratoplasty in atopy. Ophthalmology 97:729-733
57. Maroun F, Raizman MB, Gallo J (1996) Effect of eye rubbing on signs and symptoms of allergic conjunctivitis in cat sensitive individuals. Invest Ophthalmol Vis Sci 37 [Suppl]:592
58. Matsunaga A, Imayama S, Sugai S et al (1996) Increased number of IgE-positive Langerhans cells in the conjunctiva of patients with atopic dermatitis. Invest Ophthalmol Vis Sci 37 [Suppl]: 1021
59. Melnik B, Plewig G (1990) Ätiopathogenese und Prävention der Atopie. Dtsch Ärztebl 87:3229-3230
60. Melnik BC, Plewig G, Tschung T (1991) Disturbances of essential fatty acid - and prostaglandin E-mediated immunregulation in atopy. Prostaglandines, Leucotrienes and Essential Fatty Acids 42:125-130
61. Neumann C, Sager N, Ramb-Lindhauer C (1991) Inhalant allergens in the pathogenesis of atopic dermatitis. Pediatr Allergy Immunol 2:12-17
62. Njaa F, Baekken T, Bjaamer D at al (1992) Levocabastine compared with sodium cromoglycate eye drops in children with birch and grass pollen allergy. Pediatr Allergy lmmunol 3:39-42
63. Odelram M (1989) Topical levocabastine versus sodium cromoglycate in allergic conjunctivitis. Allergy 44:432-436
64. Rahi A, Davies P, Ruben M et al (1977) Keratokonus and coexisting atopic disease. Br J Ophthalmol 61:761-764
65. Rajka G (1986) Natural history and clinical manifestations of atopic eczema. Clin Rev Allergy 4:3-26
66. Rao M, Victoria MS, Jabbar H et al (1981) Atopic dermatitis, asthma and eye changes in children. J Asthma 18:47-48
67. Reinhard T, Sundmacher R (1992) Perforierende Keratoplastik bei endogenem Ekzem: Eine Indikation für systemisches Ciclosporin-A - eine retrospektive Studie über 18 Patienten. Klin Mbl Augenheilkd 201:159-163
68. Reinhard T, Möller M, Sundmacher R (1999) Penetrating kerartoplasty in patients with atopic dermatitis with and without systemic cyclosporine A. Cornea (submitted)
69. Rich LF, Hanifin JM (1985) Ocular complications of atopic dermatitis and other eczemas, lnt Opthalmol Clin 25:4-76
70. Rinas M, Kjellmann NIM, Blychert et al (1990) Topical levocabastine protects better than sodium cromoglycate and placebo in conjunctiuval provocation tests. Allergy 45:18-25
71. Ring J (1985) Erstbeschreibung einer atopischen Familienanamnese im Julisch-Claudischen Kaiserhaus: Augustus, Claudius, Britannicus. Hautarzt 36:470
72. Ring J (1991) Atopy: condition, disease, or syndrome? In: Ruzicka T, Ring J, Przybilla B (eds) Therapy of atopic eczema. Handbook of atopic eczema. Springer, Berlin New York Tokyo, pp 9-14
73. Roat Ml, Ohji M, Hunt LE et al (1993) Conjunctival epithelial cell hypermitosis and globlet cell hyperplasia in atopic keratoconjunctivitis.Am J Ophthalmol 116:456-463
74. Ruzicka T (1997) Atopie und atopisches Ekzem. ln:Braun-Falco O, Plewig G, Wolff HH (Hrsg) Dermatologie und Venerologie. 4. Aufl. Springer, Berlin Heidelberg New York, pp 445-460
75. Ruzicka T, Wüthrich B (1997) Das atopische Ekzem. Neue pathophysiologische Konzepte und exogene Provokationsfaktoren. Dtsch Ärztebl 94:A1797-1802
76. Ruzicka T, Wüthrich B (1997) Das integrierte Therapiekonzept des atopischen Ekzems. Implementierung ganzheitlicher und naturheilkundlicher Prinzipien in der universitären Medizin. Dtsch Ärztebl 94:A1874-1880
77. Ruzicka T, Assmann T, Homey B (1999) Tacrolimus? the drug for the turn of the millenium? Arch Dermatol (in press)
78. Sager N, Feldmann A, Schillingh G et al (1992) House dust mite-specific T-cells in the skin of subjects with atopic dermatitis: frequency and lymphokine profile in the allergen patch. J Allergy Clin Immunology 89:801-810
79. Schachner L, Ling NS, Press S (1983) A statistical analysis of a pediatric dermatology clinic. Pediatr Dermatol 1:157-164
80. Schaefer H, Zesch A, Schalla W, Stüttgen G (1984) Pharmakokinetik externer Glukokortikoide.Allergologie 3:194-198
81. Seamone CD, Jackson WB (1997) Immunology of the external eye. ln:Tasman W, Jaeger EA (eds). Duane's clinical opthalmology, vol 4. Lippincott-Raven, Philadelphia New York, chapter 2, pp 1-52
82. Secchi AG, Tognon S, Leonardi A (1990) Topical use of cyclosporine in the treatment of vernal keratoconjunctivitis. Am J Ophthalmol 110:641-645
83. Smolin G, Thott R (1983) The cornea. 1st edn. Little, Brown and Company, Boston Toronto, pp 234-242
84. Sundmacher R (1984) Gemeinsamkeiten und Unterschiede der Keratoconjunctivitis vernalis und Keratokonjunktivitis atopica. Klin Mbl Augenheilkd 184:149-150
85. Sundmacher R, Witschel H (1982) Keratokonjunktivitis vernalis. In: Doden W (Hrsg) Bücherei des Augenarztes. Limbusprobleme. Enke, Stuttgart, 88:95-112
86. Sustiel A, Rocklin R (1989) T cell responses in allergic rhinitis, asthma and atopic dermatitis. Clin Exp Allergy 19:11-18
87. Trocmé SD, Raizman MB, Bartley GB (1992) Medical therapy for ocular allergy. Mayo Clin Proc 67:557-565
88. Tuft SJ, Kemeny DM, Dart JKG et al (1991) Clinical features of atopic keratoconjuctivitis. Ophthalmology 98:150-158
89. Tuft SJ, Cree IA, Woogs M et al (1998) Limbal vernal keratoconjunctivitis in the tropics. Ophthalmology 105:1489-1493
90. Uehara M (1991) Dry skin and inflammation. In: Ruzicka T, Ring J, Przybilla B (eds) Therapy of atopic eczema. Handbook of atopic eczema. Springer, Berlin New York Tokyo, pp 84-89
91. Vajpayee RB, Gupta SK, Barejy U (1990) Ocular atopy and mycotic keratitis. Ann Ohthalmol 22:369-372
92. Vetter G (1952) Eine weitere Beobachtung von doppelseitiger Amotio bei Cataracta syndermatotica bilateralis. Klin Monatsbl Augenheilkd 120:264-265
93. Williams DL (1997) A comparative approach to topical cyclosporine therapy. Eye 11:453-464